Jeevan Scientific Technology (BOM:538837) Research & Development: ₹0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:538837 Jeevan Scientific Technology Ltd BOM:538837
65 GF Score
Price ₹72.77
GF Value ₹61.75
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Jeevan Scientific Technology Research & Development?

Jeevan Scientific Technology BOM:538837 +1.17% 65 Research & Development is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:538837 with a GF Score™ of 65/100 and a GF Value™ of ₹61.75 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Jeevan Scientific Technology's Research & Development for the three months ended in Mar. 2026 was ₹0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

Jeevan Scientific Technology  (BOM:538837) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Jeevan Scientific Technology Research & Development Related Terms

Jeevan Scientific Technology Research & Development Historical Data

* Premium members only.

The historical data trend for Jeevan Scientific Technology's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jeevan Scientific Technology Research & Development Chart

Jeevan Scientific Technology Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Jeevan Scientific Technology Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:538837
65GF Score
Jeevan Scientific Technology Ltd BOM:538837
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jeevan Scientific Technology Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0.0 Mil mean?
Jeevan Scientific Technology (BOM:538837) has a Research & Development of ₹0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Jeevan Scientific Technology and its competitors.
Is Jeevan Scientific Technology's Research & Development too high?
Jeevan Scientific Technology's current Research & Development is ₹0.0 Mil. Overall, Jeevan Scientific Technology has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jeevan Scientific Technology's Research & Development compare to VRTX and REGN?
Jeevan Scientific Technology's Research & Development of ₹0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Jeevan Scientific Technology and its competitors. Jeevan Scientific Technology's current Research & Development is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeevan Scientific Technology stock overvalued right now?
Based on GuruFocus' analysis, Jeevan Scientific Technology (BOM:538837) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹61.75, compared to a current price of ₹72.77 — trading 17.8% above its estimated fair value. The current Research & Development is ₹0.0 Mil. Jeevan Scientific Technology's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Jeevan Scientific Technology (BOM:538837), the current Research & Development is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jeevan Scientific Technology (BOM:538837) Overvalued in 2026?

Based on GuruFocus' analysis, Jeevan Scientific Technology stock appears to be overvalued. The current stock price of ₹72.77 is trading 17.8% above its estimated GF Value™ of ₹61.75. GuruFocus considers Jeevan Scientific Technology to be Modestly Overvalued.

Key valuation signals for BOM:538837:

  • Research & Development: ₹0.0 Mil
  • GF Value™: ₹61.75 vs. price of ₹72.77 (17.8% above fair value)
  • GF Score™: 65/100 with 5 warning signs

No single metric tells the full story. See the BOM:538837 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jeevan Scientific Technology Business Description

Address Sai Krupa Enclave, Plot No. 1 and 2, Golconda Post, Near Lanco Hills, Hyderabad, TG, IND, 500008
Jeevan Scientific Technology Ltd is an India-based company engaged in providing clinical research and data management services. Jeevan Scientific is an independent clinical contract research organization, offering reliable, cost-effective, and technology-driven clinical research solutions to various clients across the globe. Its services offer high-value testing services, including bioanalytical services for small and large molecules, ranging across generics, biosimilars, and other new drugs. It operates in a single segment, namely clinical research services.
65GF Score

Get the complete analysis for BOM:538837

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹72.77
Price
₹61.75
GF Value